This cross-sectional study investigates trends in out-of-pocket costs for unmixed and novel glucagon formulations among patients with Medicare Advantage and commercial insurance from 2010 to 2020.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428735 | PMC |
http://dx.doi.org/10.1001/jamanetworkopen.2022.29428 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!